|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL STUDIES |
Departments of1 , Internal Medicine2 Surgery, University of Pisa, Via Roma 67, 56126 Pisa, Italy
(Correspondence should be addressed to G Bernini; Email: g.bernini{at}med.unipi.it)
| Abstract |
|---|
|
|
|---|
Results: In PHEOs, at variance with the expected reduction in metanephrines and catecholamines, no variation in body weight, blood pressure and lipid profile was observed after operation. IMT and C-IBS values in patients with PHEO were greater (at least P<0.01) than in controls. At long-term follow-up after surgery, a significant reduction in mean carotid IMT (P<0.0009) and C-IBS (P<0.009) values was observed. A significant correlation (r=0.54, P<0.03) was found between absolute reduction in C-IBS values and absolute decrement in urinary normetanephrine levels.
Conclusions: Our study shows that normalization of catecholamine levels after the removal of PHEO improves carotid IMT and reduces carotid wall fibrosis even without influencing blood pressure and lipid profile. These findings confirm that high catecholamine tone in humans directly influences vascular remodelling of carotid arteries.
| Introduction |
|---|
|
|
|---|
-adrenoceptors, concerns an increase in extracellular matrix, with consequent wall fibrosis and eutrophic remodelling. Moreover, in animal models employing balloon injury of the carotid or aorta, an exacerbation of this action may be observed with proliferation, hypertrophy and migration of smooth muscle cells and adventitial fibroblasts, leading to hypertrophic remodelling (1, 4, 5, 6, 7, 8, 9). The direct influence of sympathetic neurotransmitters on vascular wall structure has been supported by studies using
-adrenoceptor antagonists that showed a reduction in proliferation of vascular wall cells and in neointimal growth after vascular injury (9, 10, 11, 12, 13). Finally, these findings have also been confirmed by the suppression in wall growth observed after local or systemic sympathetic denervation in animal experiments (14). Studies in humans, demonstrating the role of the sympathetic activity on arterial remodelling are lacking, even if the relationship found in aging between the increments of peripheral intima–media thickness (IMT) and muscle sympathetic nerve activity seems to suggest this possibility. In addition, in patients with phaeochromocytoma (PHEO), studies conducted by micromyographic technique on the small resistance arteries have demonstrated that high catecholaminergic tone is associated with eutrophic vascular remodelling (15, 16, 17). Our group recently confirmed that also in conduit arteries (carotid) of patients with PHEO a sustained vascular remodelling with fibrosis may likewise be detected, through the ultrasound and ultrasonic integrated backscatter signal (IBS) technique (18). The latter is based on an analysis of unprocessed radiofrequency signals to derive quantitative ultrasonic index. This technique has been largely utilized to evaluate collagen content of the myocardium extracellular matrix, which represents an important source of myocardial IBS (19), and able to differentiate normal from pathological myocardial structures (20, 21). Also, structural alterations of the vessel wall, such as fibrosis, calcification or deposition of lipids, may be accurately identified with this method (22). Thus, acoustic densitometry is now believed to be a clinically applicable ultrasonic backscatter imaging technology that provides an integrated online capability to measure, display and quantify the presence of fibrous tissue in intima–media complex of human arteries. This relatively simple, repeatable and quantitative analysis is able to evaluate the vascular structure in a non-invasive manner (23).
The aim of our study was to investigate, by using IBS analysis, the carotid wall characteristics of patients with PHEO before and after surgical cure.
| Materials and methods |
|---|
|
|
|---|
Eleven patients with PHEO (51±13.2 years, mean±S.D., range 28–58 years) were consecutively selected for the study. The patients were recruited among those referred to our Hypertension Centre and the Endocrinological Unit of Pisa University. Diagnosis was made in all cases by standardized protocols, including hormonal, morphological (MR and scintigraphy) and, when appropriate, genetic investigations. Five patients had sporadic PHEO (two of them presenting as asymptomatic adrenal incidentalomas), three had PHEO associated with von Hippel–Lindau disease and three associated with multiple endocrine neoplasia 2A. The latter patients did not show hyperparathyroidism, except one who was excluded from the study since high PTH levels may per se affect the vascular wall. Thus, data of ten patients were used for the investigation. In all cases, PHEO was monolateral (right-sided in six and left-sided in four) with maximum diameter ranging from 2.8 to 4.6 cm. No patient showed paroxysmal hypertension and none was under antihypertensive therapy because hypertension had only recently been diagnosed and blood pressure values were, on average, only slightly abnormal. This finding is only apparently surprising because of the amount of non-sporadic PHEO we studied (usually associated with normal, non-parossistic, blood pressure) may justify the observed unusual haemodynamic picture.
Ten age- and blood pressure-matched never treated consecutive subjects (49.1±12.4 years, mean±S.D., range 29–66 years) were also enrolled as a control group. Their mean blood pressure corresponded to high normal hypertension, as defined following the recent guidelines (24).
Experimental design
Clinical, hormonal and vascular investigations were performed in all subjects studied. In addition, in patients with PHEO, the analyses were repeated after surgical removal of the mass, using the laparoscopic approach. Histological examination consistently confirmed the diagnosis of PHEO. After surgery, two evaluations were performed: the first after 20.5±1.8 months and the second after 31.5±2.2 months. The study was approved by the local ethical committee and patients gave their informed consent.
Assays
Patients and controls, without observing a specific diet, presented in the morning (0800 and 0900 h) after overnight fasting carrying 24 h urine collection for noradrenaline, adrenaline, normetanephrine and metanephrine determination. Then, blood samples for catecholamine measurement were taken in supine position 10 min after insertion of a cannula into an antecubital vein. Clinic blood pressure was measured according to the recent guidelines (at least two measurements spaced by 1–2 min, and additional measurement if the first two were quite different in patients seated for several minutes in a quiet room) by using a mercury sphygmomanometer (24). Ambulatory blood pressure monitoring was also recorded (Spacelabs Medical, Issaquah, WA, USA) in four sporadic and four syndromic PHEOs. All subjects were caffeine-, alcohol- and smoking-free for at least 48 hrs and did not assume substances or drugs affecting cardiovascular system.
Plasma catecholamines were measured by high-pressure liquid chromatography (25), where intra- and inter-assay coefficients of variation were respectively 14% and 20% for noradrenaline and 17% and 22% for adrenaline. Intra- and inter-assay coefficients of variation of urinary hormones were respectively 14% and 20% for noradrenaline, 17% and 22% for adrenaline, 7% and 12.7% for normetanephrine and 18.7% and 11.9% for metanephrine (Immuno Biological Laboratories, Hamburg, Germany). Normal values in supine position in our laboratory were as follows: urinary normetanephrine <3.27 µmol/24 h, urinary metanephrine <1.91 µmol/24 h, urinary noradrenaline <472.88 nmol/24 h, urinary adrenaline <109.16 nmol/24 h, plasma noradrenaline <2.36 nmol/l and plasma adrenaline <0.43 nmol/l.
Two-dimensional conventional ultrasonography
The study was performed using an HPSonos5500 (Hewlett-Packard Co., Andover, MA, USA) phased-array echograph with M-mode, two-dimensional and pulsed colour-flow Doppler capabilities. The imaging protocol involved obtaining a single longitudinal lateral view of the distal segment of the right and left common carotid arteries, by using a 7.5 MHz linear array carotid probe (26). The high-resolution images were analysed to calculate IMT, defined as thickness of the vascular intima–media complex obtained in five consecutive regions of the far wall of the common carotid artery, every 4–5 mm beginning close to the bifurcation. The value attributed to each subject was the average value among the IMT measures, five from the left and five from the right carotid artery. Intra- and inter-observer variabilities for IMT were 4.6±0.4 and 5.2±0.3% respectively. Mean common carotid diameter was defined as the line identifying the media–adventitia interface in the near to the far wall calculated automatically by averaging measurements at 0.1 mm intervals over 1 cm.
Integrated backscatter analysis (IBS)
Ultrasonic characterization by IBS analysis of the carotid wall was performed using a special software package available as an option on the HP Sonos 5500. This system is capable of providing either conventional two-dimensional envelope-detected ultrasonographic images or IBS images in which the grey level is displayed proportional to the integrated backscattered power. A maximum of 60 frames displayed at a real-time frame rate of 30 Hz (30 frames/s) are captured into cine loop memory and subsequently stored on optical disk in a digital format with the same resolution as the scan converter memory (512x512, 8 bits). The IBS image is internally calibrated in dB and has a dynamic range of
64 dB in the SONOS 5500 system. This system has a unique feature in which the transmit power, log compression and time-gain compensation values are displayed on a screen (and can be stored with the images), which allows an operator to adjust the system to the same values at every examination. For analysis of the image data, the IBS images were first retrieved from disk into the system memory and the analysis was performed off-line by two independent operators, blinded to the clinical characteristics of the study population. IBS values, expressed in dB, were measured from an operator-defined region of interest (ROI) placed in the intima–media complex, in the same regions where IMT was estimated, for a total of ten measures in each subject. The system automatically calculated the average value of the IBS, which was also displayed in dB. By adopting the adventitia as the reference object, we then corrected the IBS value (C-IBS) by subtracting the IBS value obtained from a reference ROI placed within the adventitia (23, 27).
Reproducibility of data
We determined intra- and inter-observer variabilities of tissue IBS values in ten randomly selected recordings twice by the same observer and once each by two independent observers. Intra-and inter-observer variabilities of IBS value were 2.6±0.8 and 2.8±0.4% respectively in the experimental study.
In order to avoid bias linked to different operators or to the settings of the machine, only two operators were involved in the investigation. One performed and recorded the study and the other analysed the data while blinded to all patient information. In addition, the instrument was the same, the measurements were calibrated within the individual and, finally, apparatus settings were identical, in order to reduce extrinsic and intrinsic variability of the method.
Statistical analysis
Data were expressed as mean±S.E.M. One-way ANOVA was used to compare controls and patients with PHEO. To compare data before and after surgery, the paired Student's t-test was used. Linear correlation analysis was adopted to assess relationships between variables. Stepwise multiple regression analysis was carried out to test the joint effect of different variables (hormones, blood pressure, total cholesterol, low density lipoprotein and high density lipoprotein cholesterol) on IMT parameters and on C-IBS values of carotid arteries. Only clinic blood pressure, as mean values of three different recordings, was utilized for the analysis, since paroxysmal hypertension was not observed in our patients with PHEO, as confirmed by 24 h blood pressure measurement. Thus, the mean (±S.E.M.) of S.D. of the mean 24 h systolic (PHEOs: 12.6±1.5 mmHg; hypertensives: 13.4±1.5 mmHg) and diastolic (PHEOs: 11.16±0.87 mmHg; hypertensives:12.1±1.5 mmHg) blood pressure was superimposable in the two groups of patients. Differences were considered significant when P<0.05. All statistical procedures and curve fitting for linear regression analysis were performed using the StatView program (Abacus Concepts, Inc., version 4.57, Berkeley, CA, USA).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
A direct effect of catecholamines on the vascular wall has been reported in several in vitro (1, 2) and in vivo (3, 4) studies. They show that eutrophic (collagen deposition and fibrosis) and hypertrophic (proliferation and migration of smooth muscle cells and of adventitial fibroblasts) remodelling characterizes the damages caused by catecholamines on the vascular wall (1, 4, 5, 6, 7, 8, 9). These observations have also been indirectly confirmed by using
-adrenoceptor antagonists (9, 10, 11, 12, 13) and by experiments in animals submitted to local or systemic sympathetic denervation (14).
In humans, even in physiological conditions, the elevated catecholaminergic tone associated with aging increases vascular (femoral) wall thickness (28). This finding has been better documented in patients with abnormal catecholamine tone due to PHEO. Thus, in small resistance arteries of these patients, eutrophic remodelling has been reported, using a micromyographic technique (15, 16, 17). In a recent study, we confirmed these data in conduit arteries (carotid) of patients with PHEO using a non-invasive procedure, such as ultrasonic backscatter signal technique (18). The latter is based on an analysis of unprocessed radiofrequency signals to derive quantitative ultrasonic index. This technique has been largely utilized to evaluate collagen content of the myocardium extracellular matrix (19, 20, 21) and recently employed to study the vascular structure of human arteries (22, 23). By using this method, we previously showed that carotid IMT of patients with PHEO is increased in comparison with that of essential hypertensives, independently of blood pressure values. We also reported that carotid wall thickness in patients with PHEO is sustained by collagen deposition and vascular fibrosis to a greater extent than that observed in essential hypertensives, suggesting that abnormal catecholamine levels may directly influence carotid wall remodelling in this pathological condition.
In the present study, we confirmed that patients with PHEO display increased carotid IMT and a rise in C-IBS values as compared with matched control subjects. In addition, we observed that normalization of catecholamine levels after successful removal of PHEO attenuates carotid artery IMT and reduces vascular wall fibrosis in these patients. Since blood pressure and lipid profile did not significantly change after surgery, our results seem to suggest that high catecholamine levels in humans directly influence vascular remodelling of conduit arteries, independently of haemodynamic discharge and of the known factors affecting the vascular wall.
An interesting finding we observed is that IMT tended to decrease in the short term but was significantly reduced only in the long-term post-surgery period. By contrast, decrement in vascular fibrosis appeared early and was further enhanced over time, despite unchanged blood pressure. Thus, fibrosis reduction seems to be an event detectable after a few months by backscatter analysis, while vascular wall thickness reduction may be observed by conventional ultrasonography after a more prolonged period of time. This finding may explain the relationship observed only between C-IBS (but not IMT) and catecholamine reduction.
Our study population was particular, since the blood pressure of these patients was high normal/mild, without paroxysmal crises. The haemodynamic picture of the patients is only apparently surprising, since half of them had syndromic PHEO in which the tumour is usually poor or completely asymptomatic, while two out of five sporadic PHEOs presented as silent adrenal incidentalomas. In addition, our patients had lipid profile in the normal range. Thus, these patients did not take drugs that could possibly interfere with vascular structure, such as antihypertensive and lipid-lowering drugs. Starting from these particular clinical features, mass removal did not modify the haemodynamic and humoral parameters, except those concerning catecholamines, making plausible a direct influence of catecholamines on vascular wall. However, even whether multiple regression analysis showed that the structural changes we observed were independent of blood pressure, we are aware that the vascular haemodynamic–structural relationship is more complex than clinic blood pressure and that the small number of patients studied does not allow definitive conclusions.
Thus, in the present paper, we show that the increase in IMT and carotid vascular fibrosis of patients with PHEO is also due to a direct effect of plasma catecholamines, since their normalization is associated with an improvement in vascular structure. Therefore, our data suggest a possible role of the catecholaminergic system in the development of vascular alterations in humans.
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |